GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » Insider Ownership

Saniona AB (OSTO:SANION) Insider Ownership : 0.00 % (As of Dec. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Saniona AB Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Saniona AB's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Saniona AB's Institutional Ownership is 1.39%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Saniona AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Saniona AB Insider Ownership Historical Data

The historical data trend for Saniona AB's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saniona AB Insider Ownership Chart

Saniona AB Annual Data
Trend Jan14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Saniona AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Saniona AB Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Saniona AB Business Description

Traded in Other Exchanges
Address
Smedeland 26B, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.

Saniona AB Headlines

No Headlines